GEN Exclusives

More »

GEN News Highlights

Back to Item »

FKD Therapies Acquires Exclusive License to Merck & Co.’s Gene Therapy Portfolio

Pipeline is headed by Phase II-ready recombinant adenoviral interferon alfa 2b for treating superficial bladder cancer.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should the CDC Director Resign?

Do you think the CDC chief should resign?